Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1978 1
1980 1
1985 2
1987 2
1988 3
1989 2
1990 4
1991 3
1992 5
1993 2
1994 4
1995 3
1996 5
1997 6
1998 3
1999 8
2000 4
2001 9
2002 6
2003 6
2004 9
2005 9
2006 5
2007 9
2008 17
2009 17
2010 12
2011 10
2012 9
2013 9
2014 8
2015 12
2016 12
2017 5
2018 3
2019 8
2020 9
2021 10
2022 8
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

262 results

Results by year

Filters applied: . Clear all
Page 1
High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S, Busschaert P, Qian J, Vanderstichele A, Loverix L, Van Gorp T, Van Nieuwenhuysen E, Han S, Van den Broeck A, Coosemans A, Van Rompuy AS, Lambrechts D, Vergote I. Olbrecht S, et al. Genome Med. 2021 Jul 9;13(1):111. doi: 10.1186/s13073-021-00922-x. Genome Med. 2021. PMID: 34238352 Free PMC article.
Stratifying patients based on marker genes specific for these phenotypes represents a promising approach to predict prognosis or response to therapy....
Stratifying patients based on marker genes specific for these phenotypes represents a promising approach to predict prognosis or response to …
Liquid Biopsy in Glioblastoma.
Ronvaux L, Riva M, Coosemans A, Herzog M, Rommelaere G, Donis N, D'Hondt L, Douxfils J. Ronvaux L, et al. Cancers (Basel). 2022 Jul 13;14(14):3394. doi: 10.3390/cancers14143394. Cancers (Basel). 2022. PMID: 35884454 Free PMC article. Review.
Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Despite recent advances in therapy modalities, the overall survival of GBM patients remains poor. ...
Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Despite recent advances in therapy modalities, the overall …
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study.
Froyman W, Landolfo C, De Cock B, Wynants L, Sladkevicius P, Testa AC, Van Holsbeke C, Domali E, Fruscio R, Epstein E, Dos Santos Bernardo MJ, Franchi D, Kudla MJ, Chiappa V, Alcazar JL, Leone FPG, Buonomo F, Hochberg L, Coccia ME, Guerriero S, Deo N, Jokubkiene L, Kaijser J, Coosemans A, Vergote I, Verbakel JY, Bourne T, Van Calster B, Valentin L, Timmerman D. Froyman W, et al. Lancet Oncol. 2019 Mar;20(3):448-458. doi: 10.1016/S1470-2045(18)30837-4. Epub 2019 Feb 5. Lancet Oncol. 2019. PMID: 30737137 Free article. Clinical Trial.
Trial watch: chemotherapy-induced immunogenic cell death in oncology.
Sprooten J, Laureano RS, Vanmeerbeek I, Govaerts J, Naulaerts S, Borras DM, Kinget L, Fucíková J, Špíšek R, Jelínková LP, Kepp O, Kroemer G, Krysko DV, Coosemans A, Vaes RDW, De Ruysscher D, De Vleeschouwer S, Wauters E, Smits E, Tejpar S, Beuselinck B, Hatse S, Wildiers H, Clement PM, Vandenabeele P, Zitvogel L, Garg AD. Sprooten J, et al. Oncoimmunology. 2023 Jun 3;12(1):2219591. doi: 10.1080/2162402X.2023.2219591. eCollection 2023. Oncoimmunology. 2023. PMID: 37284695 Free PMC article. Review.
Orientation of Preclinical Research in Ovarian Cancer.
Baert T, Garg AD, Agostinis P, Vergote I, Coosemans A. Baert T, et al. Int J Gynecol Cancer. 2017 Oct;27(8):1579-1586. doi: 10.1097/IGC.0000000000001053. Int J Gynecol Cancer. 2017. PMID: 28945211 Review.
Cervical videomediastinoscopy.
Lerut T, De Leyn P, Coosemans W, Decaluwé H, Decker G, Nafteux P, Van Raemdonck D. Lerut T, et al. Thorac Surg Clin. 2010 May;20(2):195-206. doi: 10.1016/j.thorsurg.2010.01.006. Thorac Surg Clin. 2010. PMID: 20451130 Review.
However, imaging modalities, in particular positron emission tomography, have substantially decreased the need for mediastinoscopy in early stage NSCLC, while in more advanced stages the indication for primary staging and/or restaging after induction therapy is now challen …
However, imaging modalities, in particular positron emission tomography, have substantially decreased the need for mediastinoscopy in early …
Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates.
Berckmans Y, Hoffert Y, Vankerckhoven A, Dreesen E, Coosemans A. Berckmans Y, et al. Pharmaceutics. 2023 Jun 22;15(7):1792. doi: 10.3390/pharmaceutics15071792. Pharmaceutics. 2023. PMID: 37513979 Free PMC article. Review.
Current treatment strategies often do not lead to the desired outcome due to the development of therapy resistance, resulting in high relapse rates. Additionally, clinical trials testing immunotherapy against OC have failed to reach significant results to date. ...
Current treatment strategies often do not lead to the desired outcome due to the development of therapy resistance, resulting in high …
Treatment of esophageal carcinoma.
Lerut T, Coosemans W, De Leyn P, Van Raemdonck D, Deneffe G, Decker G. Lerut T, et al. Chest. 1999 Dec;116(6 Suppl):463S-465S. doi: 10.1378/chest.116.suppl_3.463s. Chest. 1999. PMID: 10619509 Review.
Anastomotic complications after esophagectomy.
Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, van Raemdonck D. Lerut T, et al. Dig Surg. 2002;19(2):92-8. doi: 10.1159/000052018. Dig Surg. 2002. PMID: 11978992 Free article. Review.
Surgical techniques.
Lerut T, Coosemans W, Decker G, De Leyn P, Moons J, Nafteux P, Van Raemdonck D. Lerut T, et al. J Surg Oncol. 2005 Dec 1;92(3):218-29. doi: 10.1002/jso.20363. J Surg Oncol. 2005. PMID: 16299783 Review.
262 results